Sentence examples for future individualization from inspiring English sources

This statistical methodology enables 'sparse' data from multiple patients to be combined to build up an integrated pharmacokinetic pharmacodynamic model, with identification of covariates that can be used for future individualization of therapy 43– 43.

The future of individualization in Europe is being largely decided today.

Under these global conditions, the future of individualization will be basically determined by four factors.

This is a serious source of concerns about the future of individualization in Europe if regarded in global comparisons.

So it is understandable why the future of individualization takes its proper place in the strategic document on the future of the Union [13: 15–16].

The future of individualization in Europe deserves special attention concerning the area of work and concerning the issues of governance at various structural levels.

Therefore, the discussions on the future of individualization in Europe have to take into account evolutionary advancements, continuities and interruptions in the manifestations of the global trend.

The economic growth and the economic distributions will be quite important for the future of individualization which has been and will be connected to the rise and the prosperity of the middle class.

Whatever the precise share of these young people, their very existence in EU countries is indicative of the potentials of future destructive individualization manifested in criminal or in generally asocial activities.

Possibly a studies of larger cohorts of patients with homogeneous tumours and treatment characteristics stratified for the various subsites would be able to establish a role for a SUVMAX cut-off value in order to investigate future treatment individualization.

10 An important task for the future is treatment individualization, eg, by identifying genetic variations in drug pathway-associated genes with an important impact on clinical outcome in patients receiving antifolates 11– 13 or the use of therapeutic drug monitoring (TDM), eg, with MTX, enabling adequate drug exposure in all patients.